October 14, 2026
Breaking
Business

Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo

admin1 min read

Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains

The post Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo appeared first on Home Page.

Leave a Comment

Your email address will not be published. Required fields are marked *